We found that the mutant peptide generated from the germline MLH1 gene was unable to elicit an immune response in either normal healthy donors or in the LS-CRC affected patient, suggesting that the mutation is intrinsically non-immunogenic. The gene discussed is MLH1; the disease is colorectal carcinoma.